Aksense Overview

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 5

Aksense General Information

Description

Operator of an innovative company intended to develop affordable, portable nucleic acid-based diagnostic panels for rapid and accurate pathogen detection. The company's device is the first portable rapid infection diagnostic biosensor to have better good-quality and safe care in healthcare settings, to improve antibiotic prescribing practices and its technology enhances public health by enabling early detection and treatment, reducing infection spread, and improving patient outcomes, enabling users to get faster recovery using cost-effective molecular tests in the market.

Contact Information

Website
www.aksense.com
Formerly Known As
Agile Biomedical, Deepmicro Biomedical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Hoxton Mix
  • 3rd Floor, 86-90, Paul Street
  • London EC2A 4NE
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • The Hoxton Mix
  • 3rd Floor, 86-90, Paul Street
  • London EC2A 4NE
  • England, United Kingdom

Aksense Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aksense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC $2.5M Completed Generating Revenue
5. Seed Round 09-May-2022 Completed Generating Revenue
4. Grant 31-Jan-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jun-2020 Completed Generating Revenue
2. Accelerator/Incubator 06-Dec-2019 $168K $168K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Aksense’s complete valuation and funding history, request access »

Aksense Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an innovative company intended to develop affordable, portable nucleic acid-based diagnostic panels for rapi
Diagnostic Equipment
London, United Kingdom
4 As of 2024

Dublin, Ireland
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aksense Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Diagnostics Venture Capital-Backed Dublin, Ireland
Day Zero Diagnostics Venture Capital-Backed Boston, MA
Inflammatix Venture Capital-Backed Sunnyvale, CA
Grapheal Venture Capital-Backed Grenoble, France
MFluidX Venture Capital-Backed Oakland, CA
You’re viewing 5 of 5 competitors. Get the full list »

Aksense Executive Team (4)

Name Title Board Seat
Asiye Karakullukcu Co-Founder & Chief Executive Officer
Izzet Kale Chief Technology Officer & Board Member
Volkan Turgul Ph.D Chief Scientific Officer & Board Member
Mürsel Baydemir Co-Founder
To view Aksense’s complete executive team members history, request access »

Aksense Board Members (2)

Name Representing Role Since
Izzet Kale Aksense Chief Technology Officer & Board Member
Volkan Turgul Ph.D Aksense Chief Scientific Officer & Board Member
To view Aksense’s complete board members history, request access »

Aksense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aksense Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
SOSV Venture Capital Minority
Tübitak Government Minority
MedTech Innovator Accelerator/Incubator Minority
RebelBio Accelerator/Incubator Minority
İTÜ Çekirdek Accelerator/Incubator
To view Aksense’s complete investors history, request access »

Ready to get started?

Request a free trial

Aksense FAQs

  • Who is the founder of Aksense?

    Asiye Karakullukcu and Mürsel Baydemir are the founders of Aksense.

  • Who is the CEO of Aksense?

    Asiye Karakullukcu is the CEO of Aksense.

  • Where is Aksense headquartered?

    Aksense is headquartered in London, United Kingdom.

  • What is the size of Aksense?

    Aksense has 4 total employees.

  • What industry is Aksense in?

    Aksense’s primary industry is Diagnostic Equipment.

  • Is Aksense a private or public company?

    Aksense is a Private company.

  • What is Aksense’s current revenue?

    The current revenue for Aksense is .

  • How much funding has Aksense raised over time?

    Aksense has raised $2.71M.

  • Who are Aksense’s investors?

    SOSV, Tübitak, MedTech Innovator, RebelBio, and İTÜ Çekirdek have invested in Aksense.

  • Who are Aksense’s competitors?

    Novus Diagnostics, Day Zero Diagnostics, Inflammatix, Grapheal, and MFluidX are competitors of Aksense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »